Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Hormone-Dependent Neoplasms

thiazoles has been researched along with Hormone-Dependent Neoplasms in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's4 (36.36)29.6817
2010's3 (27.27)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Corbaux, P; Sabatier, R1
Cheung, P; Kakit, C; Kiess, N; Parsons, R; Pegno, S; Poulikakos, PI; Schmidt, H; Stratikopoulos, EE; Szabolcs, M; Wu, X1
Barry, WT; Febbo, PG; Guinney, J; Mendiratta, P; Mostaghel, E; Nelson, PS; Porrello, A; Tewari, AK1
Li, SH; Pang, B; Qian, XL; Shi, QG; Wang, J; Wang, LL; Wu, RQ; Xie, BX; Yu, L; Zhang, H; Zhou, JG1
Araujo, JC; Chatterji, T; Dayyani, F; Gallick, GE; Logothetis, CJ; Song, JH; Trudel, GC; Varkaris, A1
Ehrenborg, E; Gustafsson, MC; Harris, AL; Jarvis, M; Knight, D; Marshall, BR; Palmer, CN; Stephen, RL; Tatoud, R; Wolf, CR1
Limonta, P; Montagnani Marelli, M; Moretti, RM; Motta, M; Sala, A1
Blagosklonny, MV; Neckers, LM1
Bradshaw, TD; Paull, KD; Schultz, RJ; Shi, DF; Stevens, MF; Wrigley, S1
Limonta, P; Montagnani Marelli, M; Moretti, RM; Motta, M1
Ip, MM; Schenkel, L; Sylvester, PW1

Other Studies

11 other study(ies) available for thiazoles and Hormone-Dependent Neoplasms

ArticleYear
[New European approvals: Alpelisib for HRpos/HER2neg metastatic breast cancer with PIK3CA mutation].
    Bulletin du cancer, 2020, Volume: 107, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Class I Phosphatidylinositol 3-Kinases; Clinical Trials as Topic; Drug Approval; Drug Resistance, Neoplasm; Estrogens; Female; Fulvestrant; Humans; Male; Multicenter Studies as Topic; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Progesterone; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Thiazoles

2020
Mouse ER+/PIK3CA
    Oncogene, 2019, Volume: 38, Issue:1

    Topics: Aniline Compounds; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Cocarcinogenesis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutation, Missense; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Sulfonamides; Thiazoles

2019
Genomic strategy for targeting therapy in castration-resistant prostate cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Apr-20, Volume: 27, Issue:12

    Topics: Androgen Antagonists; Androgens; Dasatinib; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Humans; Male; Neoplasms, Hormone-Dependent; Oligonucleotide Array Sequence Analysis; Orchiectomy; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Receptors, Androgen; Signal Transduction; src-Family Kinases; Thiazoles

2009
The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.
    Asian journal of andrology, 2010, Volume: 12, Issue:3

    Topics: Adenocarcinoma; Androgens; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, cdc; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radiation Tolerance; Tetrazolium Salts; Thiazoles

2010
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer.
    The Prostate, 2013, Volume: 73, Issue:9

    Topics: 3T3 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dasatinib; Docetaxel; Enzyme-Linked Immunosorbent Assay; Humans; Insulin-Like Growth Factor I; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Osteoblasts; Prostatic Neoplasms; Pyrimidines; Taxoids; Thiazoles; Xenograft Model Antitumor Assays

2013
Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.
    Cancer research, 2004, May-01, Volume: 64, Issue:9

    Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Expression; Genes, cdc; Genes, Reporter; Humans; Ligands; Luciferases; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Response Elements; RNA, Messenger; Signal Transduction; Thiazoles; Transcription Factors; Transcriptional Activation

2004
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.
    International journal of cancer, 2004, Oct-20, Volume: 112, Issue:1

    Topics: Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Division; Humans; Hydroxyeicosatetraenoic Acids; Linoleic Acid; Male; Neoplasms, Hormone-Dependent; Nerve Tissue Proteins; Nuclear Receptor Subfamily 1, Group F, Member 1; Prostatic Neoplasms; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiosemicarbazones; Trans-Activators; Tumor Cells, Cultured

2004
Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines.
    Cancer letters, 1994, Jan-30, Volume: 76, Issue:2-3

    Topics: Androgens; Antineoplastic Agents; Diethylstilbestrol; Estrogens; Glucocorticoids; Gonadal Steroid Hormones; Humans; Leukemia; Neoplasms, Hormone-Dependent; Progesterone; Steroids; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1994
2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.
    British journal of cancer, 1998, Volume: 77, Issue:5

    Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Carcinoma; Cell Cycle; Colonic Neoplasms; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Estrogens; Female; Growth Inhibitors; Humans; Kidney Neoplasms; Male; Melanoma; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Skin Neoplasms; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured

1998
Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells.
    International journal of cancer, 2001, Jun-01, Volume: 92, Issue:5

    Topics: Androgens; Antineoplastic Agents; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Humans; Male; Neoplasms, Hormone-Dependent; Nuclear Receptor Subfamily 1, Group F, Member 1; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiosemicarbazones; Trans-Activators; Tumor Cells, Cultured

2001
Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
    Cancer research, 1986, Volume: 46, Issue:4 Pt 1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Corticosterone; Female; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prolactin; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Thiazoles; Thiazolidines

1986